Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.1295
-0.0351 (-21.32%)
At close: Nov 20, 2026, 4:00 PM EST
0.1350
+0.0055 (4.25%)
After-hours: Nov 20, 2026, 7:52 PM EST
Co-Diagnostics Revenue
Co-Diagnostics had revenue of $282.88K in the quarter ending September 30, 2026, with 94.58% growth. This brings the company's total for the last twelve months to $858.89K, up 69.11% year-over-year. In the year 2025, Co-Diagnostics had annual revenue of $622.49K, down -84.10%. That makes Co-Diagnostics the 43,870th largest company in the world by revenue and 6,165th in the United States.
Revenue (ttm)
$858.89K
Revenue Growth
+69.11%
P/S Ratio
1.58
Revenue / Employee
$7,469
Employees
115
Market Cap
1.36M
Revenue by Geography
- United States 581.55K 93.4%
- Rest of World 40.94K 6.6%
Fiscal year ended Dec 31, 2025 See the full Co-Diagnostics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 622.49K | -3.29M | -84.10% |
| Dec 31, 2024 | 3.92M | -2.90M | -42.53% |
| Dec 31, 2023 | 6.81M | -27.41M | -80.09% |
| Dec 31, 2022 | 34.22M | -63.67M | -65.04% |
| Dec 31, 2021 | 97.89M | 23.33M | 31.30% |
| Dec 31, 2020 | 74.55M | 74.34M | 34,579.90% |
| Dec 31, 2019 | 214.97K | 175.06K | 438.63% |
| Dec 31, 2018 | 39.91K | 32.25K | 420.90% |
| Dec 31, 2017 | 7.66K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 10.00K | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 20.53M |
| Nuwellis | 9.01M |
| Beyond Air | 8.19M |
| INVO Fertility | 8.00M |
| Tenon Medical | 5.57M |
| 20/20 Biolabs | 2.00M |
| Nexalin Technology | 277.31K |
| Adagio Medical Holdings | 137.00K |
CODX News
- 2 days ago - Co-Diagnostics announces reverse stock split - TheFly
- 2 days ago - Co-Diagnostics Announces Reverse Stock Split - PRNewsWire
- 4 days ago - Co-Diagnostics receives Logix Smart ZDC test orders from Peru and Bolivia - TheFly
- 4 days ago - Co-Diagnostics Receives Logix Smart® ZDC Test Order from Peru Distributor as Dengue Cases Rise and Exhibits at MEDICA 2026 in Düsseldorf - PRNewsWire
- 11 days ago - Co-Diagnostics Earnings Call Transcript: Q3 2026 - Transcripts
- 11 days ago - Co-Diagnostics Earnings release: Q3 2026 - Filings
- 11 days ago - Co-Diagnostics Quarterly report: Q3 2026 - Filings
- 12 days ago - Co-Diagnostics Reports Third Quarter 2026 Financial Results - PRNewsWire